These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 5964116)

  • 41. [Mucoviscidosis/cystic fibrosis (CF)].
    Lindemann H
    Pneumologie; 1996 Sep; 50 Suppl 2():588-91. PubMed ID: 9157421
    [No Abstract]   [Full Text] [Related]  

  • 42. [Amino acids in the stools of patients with cystic fibrosis].
    Filipović D; Hajduković R
    Srp Arh Celok Lek; 1974; 102(10-11):779-83. PubMed ID: 4456624
    [No Abstract]   [Full Text] [Related]  

  • 43. Drug disposition in cystic fibrosis: progress in understanding pathophysiology and pharmacokinetics.
    Prandota J
    Pediatr Infect Dis J; 1987 Dec; 6(12):1111-26. PubMed ID: 3324042
    [No Abstract]   [Full Text] [Related]  

  • 44. [Clinical and anatomo-pathological aspects of mucoviscidosis. A study of 36 cases].
    Mastella G; Battaglino G; Garofalo E
    Fracastoro; 1966; 59(5):472-523. PubMed ID: 5993200
    [No Abstract]   [Full Text] [Related]  

  • 45. [Role of the liver in mucoviscidosis (cystic fibrosis). Results of clinical and biopsy studies].
    Mücke D; Kranz D; Kunz W; Gmyrek D
    Dtsch Gesundheitsw; 1971 Dec; 26(51):2418-24. PubMed ID: 5148594
    [No Abstract]   [Full Text] [Related]  

  • 46. Enhanced intestinal glucose and alanine transport in cystic fibrosis.
    Baxter P; Goldhill J; Hardcastle J; Hardcastle PT; Taylor CJ
    Gut; 1990 Jul; 31(7):817-20. PubMed ID: 2370017
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Nodular purpura in a suckling infant with mucoviscidosis].
    Balsamo V; Corso D
    Pediatria (Napoli); 1968 Apr; 76(2):256-66. PubMed ID: 5738819
    [No Abstract]   [Full Text] [Related]  

  • 48. [Some absorption mechanisms of the small intestine with particular reference to the absorption of carbohydrates].
    Ksiazkiewicz-Szapiro MD
    Pol Tyg Lek; 1966 May; 21(22):851-4. PubMed ID: 5336087
    [No Abstract]   [Full Text] [Related]  

  • 49. Thyroid function in cystic fibrosis patients compared with healthy Israeli children.
    Sack J; Blau H; Amado O; Katznelson D
    Isr J Med Sci; 1983 Jan; 19(1):17-9. PubMed ID: 6832944
    [No Abstract]   [Full Text] [Related]  

  • 50. Antioxidant status in erythrocytes of cystic fibrosis children.
    Laskowska-Klita T; Chełchowska M
    Acta Biochim Pol; 2001; 48(1):283-5. PubMed ID: 11440181
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Studies on resorption of orally administered antibiotics and chemotherapeutic agents in children and its modification. 2].
    Guggenbichler JP
    Padiatr Padol; 1982; 17(3):565-84. PubMed ID: 7110736
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Absorption of orally-administered cotrimoxazole in patients with cystic fibrosis].
    Antonelli M; De Angelis M; Bravo E; Lorusso G; Ascalone V
    Minerva Pediatr; 1982 Nov; 34(21):933-7. PubMed ID: 7155098
    [No Abstract]   [Full Text] [Related]  

  • 53. [Digestion and absorption of carbohydrates].
    Launiala K
    Duodecim; 1966; 82(21):1008-13. PubMed ID: 5333503
    [No Abstract]   [Full Text] [Related]  

  • 54. [Copper and zinc levels in nails of children with cystic fibrosis, carriers and healthy controls (author's transl)].
    Escobar H; Arroyo M; Suárez L; Camarero C; Crespo E; Vera C
    An Esp Pediatr; 1980 Feb; 13(2):127-32. PubMed ID: 7396268
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Use of kinesitherapy in the management of mucoviscidosis].
    Bessac Y; Loeuille GA
    Lille Med; 1981 Mar; 26(3):107-9. PubMed ID: 7289739
    [No Abstract]   [Full Text] [Related]  

  • 56. Maldigestion and malabsorption of 13C labelled tripalmitin in gastrostomy-fed patients with cystic fibrosis.
    Laiho KM; Gavin J; Murphy JL; Connett GJ; Wootton SA
    Clin Nutr; 2004 Jun; 23(3):347-53. PubMed ID: 15158298
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Specialized products for nutrition of children with mucoviscidosis].
    Solomadina LV; Kruglik VI; Ladodo KS; Borovik TE; Roslavtseva EA; Semenova NN; Kapranov NI; Kashirskaia NIu
    Vopr Pitan; 1995; (2):17-20. PubMed ID: 7483462
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Myocardial damage in mucoviscidosis].
    Matoga S; Skuza B
    Pediatr Pol; 1984 Apr; 59(4):265-72. PubMed ID: 6236418
    [No Abstract]   [Full Text] [Related]  

  • 59. [Prospects of children with mucoviscidosis].
    Houstĕk J; Vávrová V
    Cesk Pediatr; 1967 May; 22(5):458-66. PubMed ID: 6081556
    [No Abstract]   [Full Text] [Related]  

  • 60. [Pathophysiology and therapy of mucoviscidosis].
    Bachert C
    HNO; 1996 Apr; 44(4):167-8. PubMed ID: 8655345
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.